Exchange traded funds (ETFs) surrounding pharmaceutical companies appear to be mixed up as findings from advanced drug studies pertaining to dementia are inconclusive. Both Elan Corp. (ELN) and Wyeth (WYE) said complete data from the midstage trial of their experimental drug for Alzheimer’s disease supports their decision to move the drug into more advanced studies before [...]